Interestingly, an increase in plasma GFAP levels despite decreasing PET-signals for astrogliosis over time was seen in AD [28], while an in vivo PET-imaging study in PD showed an initial upregulation followed by a downregulation of reactive astrogliosis over the disease course [29]. The gene discussed is GFAP; the disease is Parkinson disease.